Fact or Fiction with Captain Kelly
For the latest segment of “Fact or Fiction” by Icom, Captain Kelly shines a spotlight on the technological showdown between X-band and S-band radars and particularly how they’re relevant to maritime navigation and safety. This discussion comes at a time where it has become crucial amidst increasing reliance on radar technology for precision in…
Latest
Fact or Fiction with Captain Kelly
Fact or Fiction: Do All Boats Show as AIS Targets on Radar?
In this latest episode of Icom’s “Fact or Fiction,” Captain Kelly Gordon tackles a common misconception about marine radar systems: Do all boats show up on radar as AIS (Automatic Identification System) targets? Many believe every vessel on the water appears as those distinctive little triangles on radar screens, representing AIS targets. However, Captain…
Fact or Fiction with Captain Kelly
Fact or Fiction with Captain Kelly: UHF vs. VHF Radio Communication on Board
In the latest installment of Fact or Fiction with Captain Kelly Gordon, Gordon explains why her crew uses UHF radios for internal communication over VHF radios. UHF radios are preferred on board because their ultra high frequency waves penetrate vessel walls better than VHF waves. However, VHF radios are more effective for long-distance communication…
Fact or Fiction with Captain Kelly
Captain Kelly Details Some Facts About Marine VHF Radios and Their Use On Shore
In the latest episode of Icom’s “Fact or Fiction with Captain Kelly,” a pressing question is addressed that tangles with both maritime communication norms and legal nuances. For a brief explanation what’s true and what’s false into the often misunderstood regulations surrounding the use of handheld VHF radios on land is explored. Featuring Captain…
Fact or Fiction with Captain Kelly
Fact or Fiction with Captain Kelly: Motor Yacht Captain Kelly Gordon Delves Into VHF Radio’s Line-of-Sight Challenges
How does the line-of-sight limitation of VHF radio impact communication in remote or obstructed areas? Award-winning motor yacht captain and social media influencer, Captain Kelly Gordon, delved into the importance of understanding VHF radio’s line-of-sight constraints for effective communication, especially in areas without cell coverage. “If they’re on the other side of the hill,…
Latest
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…
What’s Next in Preclinical Cancer Immunotherapy Research?
As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
